THE COMBINATION OF SALBUTAMOL NEBULIZER AND PROCATEROL ORAL TO THE INDONESIAN CHILDREN WITH PNEUMONIA

L. Kusumawati, E. Darmawan, Nurcholid Umam Kurniawan
{"title":"THE COMBINATION OF SALBUTAMOL NEBULIZER AND PROCATEROL ORAL TO THE INDONESIAN CHILDREN WITH PNEUMONIA","authors":"L. Kusumawati, E. Darmawan, Nurcholid Umam Kurniawan","doi":"10.55047/comorbid.v1i2.77","DOIUrl":null,"url":null,"abstract":"\nThis study aimed to examine the effectiveness of combining salbutamol nebulizer and procaterol oral compared to only procaterol oral on the respiratory status including temperature (fever), spasm, cough, retraction and length of stay (LOS), among young children with pneumonia. This prospective cohort study included 48 consecutive sampling subjects with pneumonia in Indonesia. The subjects were classified based on the type of therapy they received: intervention group used the combination of salbutamol nebulizer and procaterol oral therapy (n = 24) and the control group used procaterol oral only (n = 24). The study of the two groups showed that the combination salbutamol nebulizer and procaterol oral was more effective than the administration of procaterol oral only with the rate of clinical change. The significant effectiveness of nebulizer salbutamol and oral procaterol to reducing respiratory status (p=0.006) and temperature (fever) (p=0.000) compared to the only procaterol oral. However, there was no significant effectiveness of nebulizer salbutamol and oral procaterol in reducing spasm (p=0.348), cough (p=0.964), retraction (p=0.666) and length of stay (LOS) (p=0.192) compared to the only procaterol oral among the Indonesian children with pneumonia. \n \n \n  \n \n \n  \n","PeriodicalId":19772,"journal":{"name":"PHARMACOLOGY, MEDICAL REPORTS, ORTHOPEDIC, AND ILLNESS DETAILS (COMORBID)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PHARMACOLOGY, MEDICAL REPORTS, ORTHOPEDIC, AND ILLNESS DETAILS (COMORBID)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55047/comorbid.v1i2.77","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

This study aimed to examine the effectiveness of combining salbutamol nebulizer and procaterol oral compared to only procaterol oral on the respiratory status including temperature (fever), spasm, cough, retraction and length of stay (LOS), among young children with pneumonia. This prospective cohort study included 48 consecutive sampling subjects with pneumonia in Indonesia. The subjects were classified based on the type of therapy they received: intervention group used the combination of salbutamol nebulizer and procaterol oral therapy (n = 24) and the control group used procaterol oral only (n = 24). The study of the two groups showed that the combination salbutamol nebulizer and procaterol oral was more effective than the administration of procaterol oral only with the rate of clinical change. The significant effectiveness of nebulizer salbutamol and oral procaterol to reducing respiratory status (p=0.006) and temperature (fever) (p=0.000) compared to the only procaterol oral. However, there was no significant effectiveness of nebulizer salbutamol and oral procaterol in reducing spasm (p=0.348), cough (p=0.964), retraction (p=0.666) and length of stay (LOS) (p=0.192) compared to the only procaterol oral among the Indonesian children with pneumonia.    
沙丁胺醇喷雾器联合口服普罗卡特罗治疗印尼肺炎患儿疗效观察
本研究旨在探讨沙丁胺醇雾化器联合口服procaterol与单独口服procaterol对肺炎患儿呼吸状态(包括体温(发热)、痉挛、咳嗽、收缩和住院时间(LOS))的影响。这项前瞻性队列研究包括48名印度尼西亚肺炎患者。根据治疗方式进行分类:干预组采用沙丁胺醇雾化器联合口服procaterol治疗(n = 24),对照组采用口服procaterol治疗(n = 24)。两组的研究表明,从临床变化率来看,沙丁胺醇雾化器联合口服procaterol比单独口服procaterol更有效。雾化沙丁胺醇和口服procaterol在降低呼吸状态(p=0.006)和温度(发烧)(p=0.000)方面的显着有效性与单独口服procaterol相比。然而,在印尼肺炎患儿中,沙丁胺醇喷雾剂和口服procaterol在减少痉挛(p=0.348)、咳嗽(p=0.964)、收缩(p=0.666)和住院时间(LOS) (p=0.192)方面没有显著效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信